Clinical Trials Directory

Trials / Unknown

UnknownNCT05364060

COVID-19 and Mental Health in Eure

Assessment of Severe Depression Related to Psychotrauma in the COVID-19 Context in Patients Followed in Psychiatry in the Department of Eure

Status
Unknown
Phase
Study type
Observational
Enrollment
585 (estimated)
Sponsor
Centre Hospitalier Eure-Seine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Research Hypothesis: Living conditions during COVID-19, and lockdowns and curfews impact the psychological state of patients (assessed by the degree of depression, positive and negative thoughts, insomnia, state of post-traumatic stress).

Detailed description

From the early stages of the COVID-19 pandemic, concerns were raised about its effect on mental health and on patients with mental illness. Several surveys and cross-sectional assessments, in Italy, England, Ecuador and China in 2020, have suggested that patients with COVID-19 have symptoms of anxiety (including stress disorder traumatic, depression and insomnia. In France, a survey by "Santé Publique France" on the impact of COVID-19 on mental health carried out in November 2020, revealed a 20% rate of depressive symptoms in the general population. The objective of this study is to assess the level of psychological distress and the prevalence of psychiatric disorders related to COVID-19 as part of the follow-up of psychiatric patients in the department of Eure since March 2020, which has coincided with the onset of the health crisis, including consecutive lockdowns and curfews.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnairesDifferent questionnaires detailed in the objectives part

Timeline

Start date
2022-06-13
Primary completion
2023-06-13
Completion
2023-06-13
First posted
2022-05-06
Last updated
2022-11-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05364060. Inclusion in this directory is not an endorsement.